Maravai Lifesciences Holdings Inc (MRVI)

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US56600D1072

Nucleic Acids, Antibodies, Enzymes, Oligonucleotides, Reagents

Maravai LifeSciences Holdings, Inc. is a life sciences company that plays a crucial role in the development of life-changing therapies, diagnostic tools, and vaccines. By providing essential products and services, the company supports researchers and scientists worldwide in their quest to combat human diseases.

The company's product portfolio is designed to support various stages of biopharmaceutical development. This includes nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during biopharmaceutical production, and products that help detect protein expression in tissues across different species.

Maravai LifeSciences operates through two main segments: Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on manufacturing and selling products used in gene therapy, vaccine development, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics. This includes reagents used in DNA and RNA synthesis, modification, labeling, and purification, as well as messenger RNA, oligonucleotides, and custom enzyme development.

The Biologics Safety Testing segment offers analytical products and services for biologic manufacturing process development. This includes custom product-specific development antibodies, assay development services, and a range of kits and reagents for detecting impurities and contaminants, such as HCP ELISA kits and viral clearance prediction kits.

Maravai LifeSciences serves a diverse range of customers, including biopharmaceutical companies, research institutions, and in vitro diagnostics companies. With its headquarters in San Diego, California, the company is well-positioned to drive innovation and advancement in the life sciences industry.

For more information about Maravai LifeSciences Holdings, Inc., please visit their website at

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Maravai Lifesciences Holdings Inc (MRVI)

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Maravai Lifesciences Holdings Inc (MRVI)

MRVI Stock Overview

Market Cap in USD 2,256m
Sector Healthcare
Industry Biotechnology
GiC SubIndustry Life Sciences Tools & Services
TER 0.00%
IPO / Inception 2020-11-20

MRVI Stock Ratings

Growth 5y -5.11
Fundamental -16.6
Dividend -
Rel. Performance vs Sector -2.83
Analysts 4.38/5
Fair Price Momentum 11.98 USD
Fair Price DCF 12.54 USD

MRVI Dividends

Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

MRVI Growth Ratios

Growth 12m -16.62%
Growth Correlation 12m -41%
Growth Correlation 3m 46%
CAGR 5y -24.17%
CAGR/Mean DD 5y -0.46
Sharpe Ratio 12m -0.25
Alpha vs SP500 12m -41.66
Beta vs SP500 5y weekly 0.86
ValueRay RSI 96.00
Volatility GJR Garch 1y 70.43%
Price / SMA 50 31.86%
Price / SMA 200 46.51%
Current Volume 1947.7k
Average Volume 20d 2051.4k

External Links for MRVI Stock

Wall Street JournalBenzingaYahoo Finance
Fund Manager Positions
What is the price of MRVI stocks?
As of May 21, 2024, the stock is trading at USD 11.34 with a total of 1,947,740 shares traded.
Over the past week, the price has changed by +7.69%, over one month by +55.34%, over three months by +113.16% and over the past year by -15.25%.
What are the forecast for MRVI stock price target?
According to ValueRays Forecast Model, MRVI Maravai Lifesciences Holdings Inc will be worth about 13.3 in May 2025. The stock is currently trading at 11.34. This means that the stock has a potential upside of +17.37%.
Issuer Forecast Upside
Wallstreet Target Price 9.9 -12.9
Analysts Target Price 13 14.6
ValueRay Target Price 13.3 17.4